Summary
Wolfpack Research released a damaging short report on UFP Technologies (UFPT), claiming the company’s growth is collapsing due to the unraveling of its largest customer relationship. The report centers on Intuitive Surgical (ISRG), which has begun insourcing surgical drape production, undermining UFPT’s core business and revealing what Wolfpack calls a façade of sustainability propped up by acquisitions and insider selling.
Who is UFP Technologies?
UFP Technologies is a medical device-focused manufacturer that supplies custom-engineered components, most notably single-use surgical drapes. Historically, UFPT has touted robust growth through its contract with ISRG, the leading maker of robotic surgical systems. With a reputation for margin strength and acquisition-fueled expansion, the company trades at a premium in the health care supplies sector. However, new evidence suggests that its business fundamentals may be rapidly deteriorating.
Key Points from Report
ISRG is Cutting UFPT Off
- UFPT’s largest customer, Intuitive Surgical, accounted for 29% of revenue and 96.5% of organic growth in 2024.
- ISRG is now insourcing surgical drapes to facilities in Mexico and Bulgaria. Import data shows a 38% drop in UFPT shipments and a pivot to competitor Microtek.
- Wolfpack believes ISRG’s revised agreement, announced March 2024, allows the customer to slash purchases without penalty, implying an annual drop from $145M to $125M or lower.
UFPT’s “Growth” May Be a Mirage
- When excluding ISRG and recent acquisitions, organic growth was just 0.4% in 2024.
- Wolfpack claims the company’s acquisition spree was a smokescreen to obscure ISRG’s declining contribution.
- Three of the four acquired companies are small, underdeveloped businesses with limited financial impact.
The AJR Acquisition: Another House of Cards?
- UFPT paid $110M for AJR Enterprises, a stagnant firm whose sole customer is Stryker.
- Post-acquisition, AJR was forced to relocate to the Dominican Republic and concede on pricing to retain Stryker’s business.
- Wolfpack suggests that AJR’s revenue boost was fueled by aggressive “bill-and-hold” accounting, a method often flagged by regulators.
Insiders Cashing Out Big
- UFPT insiders, including the CEO and CFO, dumped $51 million in stock since the amended ISRG agreement.
- This selling spree coincided with the peak of UFPT’s stock price and preceded public disclosure of ISRG’s drape insourcing.
Activ8 Finance Analysis
Wolfpack’s report presents compelling evidence that UFPT is entering a period of structural decline. The unraveling of its most important customer relationship, combined with opaque accounting and heavy insider selling, suggests a significant mismatch between perception and reality.
The company’s acquisitions appear reactive rather than strategic, and its flagship deal with AJR could expose it to further risk due to customer concentration and margin pressure. Wolfpack’s findings also raise questions about UFPT’s transparency, especially regarding when management became aware of ISRG’s plans.
While the company continues to promote its acquisition-driven expansion, investors should remain skeptical until UFPT can demonstrate genuine, diversified, and sustainable growth.